clinical trial · NCT00095004
Study to Test an Approved Product in the Early Treatment of Migraine (0462-066)
Organon and Co·phase3·completed·n = 167
MigraineMK0462, rizatriptan benzoate / Duration of Treatment: 1dayComparator: placebo / Duration of Treatment: 1 day
brief summary
The purpose of this study is to test the effectiveness of an approved drug in the early treatment of migraine.
started
Oct 21, 2004
primary completion
Apr 1, 2005
completion
Apr 4, 2005
last updated
Aug 14, 2024
official title
A Multicenter, Double-Blind, Randomized, Parallel, Placebo-Controlled Study to Examine the Efficacy of Rizatriptan 10 mg Tablet Administered Early During a Migraine Attack While the Pain is Mild
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol